Cart
sales@molnova.com
Oxepinac
CAS No. 55689-65-1
Oxepinac( —— )
Catalog No. M35997 CAS No. 55689-65-1
oxepinac is an effective and well-tolerated compound for the treatment of painful osteoarthritis. oxepinac has no teratogenic effect on mouse and rabbit fetuses in animal experiments.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 235 | In Stock |
|
| 10MG | 335 | In Stock |
|
| 25MG | 511 | In Stock |
|
| 50MG | 671 | In Stock |
|
| 100MG | 905 | In Stock |
|
| 200MG | 1218 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOxepinac
-
NoteResearch use only, not for human use.
-
Brief Descriptionoxepinac is an effective and well-tolerated compound for the treatment of painful osteoarthritis. oxepinac has no teratogenic effect on mouse and rabbit fetuses in animal experiments.
-
Descriptionoxepinac is an effective and well-tolerated compound for the treatment of painful osteoarthritis. oxepinac has no teratogenic effect on mouse and rabbit fetuses in animal experiments.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number55689-65-1
-
Formula Weight268.26
-
Molecular FormulaC16H12O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=2C(=CC(CC(O)=O)=CC2)OCC=3C1=CC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
(+)-Bicuculline meth...
(+)-Bicuculline methiodide is a γ-aminobutyric acid type A (GABAA) receptor blocker that crosses the rat blood-brain barrier (BBB) and blocks epileptogens, which can be used to study neurological disorders such as epilepsy. (+)-Bicuculline methiodide reduces liver injury in septic rats.
-
MMP-3 Substrate I, f...
MMP-3 Substrate I, fluorogenic
-
Peptide M
Peptide M is a synthetic Peptide, 50 aa, derived from streptococcus M protein, containing an additional c-terminal cysteine residue.
